Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperandrogenaemia and the ovary.

Robert J Norman1

  • 1Reproductive Medicine Unit, Department of Obstetrics and Gynaecology, The University of Adelaide, The Queen Elizabeth Hospital, Woodville Road, Woodville, Australia. robert.norman@adelaide.edu.au

Molecular and Cellular Endocrinology
|June 5, 2002
PubMed
Summary

Polycystic ovary syndrome (PCOS) is a common cause of hyperandrogenaemia in women, affecting 5-10% of the population. Interventions target hormonal imbalances and ovarian function in PCOS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medically Assisted Reproduction and Hormone-Related Cancers.

JAMA network open·2026
Same author

Novel polycystic ovary syndrome clusters identified by endocrine-metabolic clustering: impact on reproductive outcomes after fertility treatment.

Fertility and sterility·2026
Same author

Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process.

Lancet (London, England)·2026
Same author

Mapping burdens and inequalities of polycystic ovary syndrome in young females across 953 locations 1990-2040 with deep learning forecasts.

iScience·2026
Same author

Impact of glucose metabolism abnormalities on live birth rate in South-East Asian women with polycystic ovary syndrome.

Human reproduction open·2026
Same author

Cancer Incidence in Women After Medically Assisted Reproduction.

JAMA network open·2026

Area of Science:

  • Reproductive Endocrinology
  • Gynecology
  • Metabolic Disorders

Background:

  • Hyperandrogenaemia in women manifests with diverse symptoms, notably reproductive dysfunction.
  • Polycystic ovary syndrome (PCOS) is the most prevalent cause, impacting 5-10% of women globally.
  • PCOS pathogenesis involves complex genetic and environmental factors.

Purpose of the Study:

  • To summarize the key aspects of hyperandrogenaemia in women, focusing on PCOS.
  • To highlight the endocrine and ovarian dysfunctions characteristic of PCOS.
  • To outline current and potential therapeutic strategies for PCOS.

Main Methods:

  • Literature review of studies on hyperandrogenaemia and PCOS.
  • Analysis of the pathophysiology of androgen excess in PCOS.

Related Experiment Videos

  • Synthesis of information on hormonal and ovarian targets for intervention.

    • Main Results:

    • PCOS ovaries exhibit excessive androgen production.
    • Ovarian cells in PCOS show heightened sensitivity to luteinizing hormone (LH) and insulin.
    • Reproductive system issues are a common presentation of hyperandrogenaemia.

    Conclusions:

    • Effective management of PCOS requires addressing underlying hormonal imbalances.
    • Therapeutic approaches should target luteinizing hormone and insulin pathways.
    • Direct ovarian interventions are crucial for managing PCOS-related hyperandrogenaemia.